Omicron - my thought why the market has reacted3 Mar 2022 10:18
'The Company also announced that in vitro studies conducted at Viroclinics-DDL in the Netherlands have shown that SNG001 has potent antiviral activity against SARS-CoV-2 Delta and Omicron variants at concentrations that are readily achievable following inhaled delivery of interferon beta.'
Am happy to be corrected but are we not the only one in trials that have shown good results against Omicron.....therefore there is a good reason we will do well against future variants,where other companies in trials have failed against Omicron.
This is what I beleive the market has jumped on!